Researchers Tap into Smart Bed Data to Reveal Sleep-Heart Link
Sleep Number presented new research shedding light on the link between sleep abnormalities and heart failure with preserved ejection fraction.
Sleep Number presented new research shedding light on the link between sleep abnormalities and heart failure with preserved ejection fraction.
London-based LivaNova has received FDA 510(k) clearance and the European Commission's CE Mark for its Essenz In-Line Blood Monitor.
The ENGAGE registry study presents 10-year data on the Endurant stent graft for abdominal aortic aneurysm repair, showing durable performance and low mortality rates. The findings confirm the long-term efficacy of the stent graft, emphasizing the importance of lifelong surveillance for patients undergoing endovascular repair.
Read MoreThe ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) study is a comprehensive prospective investigation focusing on cardiovascular outcomes, decision-making processes, and psychosocial impacts in young competitive athletes with confirmed or suspected high-risk cardiac conditions. The study aims to provide valuable data to inform sports participation guidelines and improve our understanding of the natural history and management of cardiovascular conditions in athletes.
Read MoreA study conducted on a representative sample of older adults in the United States reveals a significant association between cardiovascular risk and cognitive function. The findings emphasize the importance of managing cardiovascular health to preserve cognitive well-being in aging populations.
Read MoreApproximately one in six patients with chronic limb-threatening ischemia (CLTI) dies within the first year of diagnosis, with mortality rates increasing to half by 5 years. The CLIPPER database offers valuable insights into CLTI mortality and quality of care, highlighting the need for improved processes and metrics. Discover the implications of this extensive database and its potential impact on the management of CLTI patients.
Read MoreThe ATLAS trial highlights the impact of implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation. Findings show that patients with transvenous leads experience worse outcomes related to tricuspid regurgitation compared to those with subcutaneous leads. Further research is needed to explore the implications of this relationship on patient health.
Read More